Q4 2025 earnings call: record $4.3B revenue, 2026 guidance, pipeline updates, and generic risks to Xywav—read key takeaways.

Here’s the insight most coverage still misses: Longevity isn’t just a market; it’s a performance multiplier. In other words, ...

Dr Reddy's Laboratories is set to launch its generic semaglutide injection, Obeda, in India this March, as patent protection ...

Everyone has access to the same AI models; the real advantage belongs to those who know how to iterate past the first draft.

Digital marketing in Zimbabwe has evolved far beyond simply maintaining an online presence. For organisations operating within a volatile and resource-constrained economic environment, digital ...

Many perceive poker as a skill-based game. But dig a bit deeper, and you’ll certainly find it involves strategy, psychology, and the ever-ubiquitous bonuses. These bonuses offer more than ...

Q4 2025 earnings call recap: 2026 revenue/EBITDA/EPS guidance, CREXONT growth, biosimilars & GLP-1 updates—read key takeaways.

South Carolina's hospitality sector faces a persistent challenge: attracting and retaining quality staff in an industry known ...

The Kahuna and Skillcentrix partnership directly addresses this problem by combining clear definitions of what “good” looks like for regulated healthcare roles with continuous, in-field validation of ...

WINTERTHUR, CH - February 26, 2026 - PRESSADVANTAGE - SEO ROI Rechner, a Winterthur-based technology company, has ...

Dallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest PatentVest Pulse report, “The Oral Small-Molecule GLP-1 ...